Displaying 1641 - 1660 of 4985
FTC Will Reschedule Roundtable with State Attorneys General
Date
The Federal Trade Commission is rescheduling a Roundtable with the State Attorneys General, which originally had been planned for March 25 as part of the agency’s Hearings Initiative, due to...
FTC Hearings on Competition and Consumer Protection in the 21st Century Continue with Discussion of Competition and Consumer Protection in Broadband Markets
Date
What: The Federal Trade Commission will host the 10th session of its Hearings on Competition and Consumer Protection in the 21st Century, which will examine competition and consumer protection in...
Nov14
Twelfth Annual Federal Trade Commission Microeconomics Conference
-
-
The Federal Trade Commission's Bureau of Economics and the Tobin Center for Economic Policy at Yale will host a two-day conference to bring together scholars working in areas related to the FTC's...
1903001 Informal Interpretation
Date
Rule
7A(c)(10)
The closings would need to be virtually simultaneous to use 7A(c)(10). 1-2 weeks between them is definitely too long.
File
Original Image
(80.06 KB)
1903006 Informal Interpretation
Date
Rule
801.10, 802.1, 802.2
Yes, you should include the real estate in the SOT, unless an exemption applies.
File
Original Image
(109.38 KB)
1903003 Informal Interpretation
Date
Rule
801.1, 803.7
Please file now, for both steps. Thank you for running this by us.
File
Original Image
(127.47 KB)
FTC Submits Annual Budget Request, Performance Plan and Performance Report to Congress
Date
The Federal Trade Commission has submitted to Congress its Fiscal Year 2020 budget request in support of the President’s FY 2020 budget for the federal government. The budget request also includes the...
FTC Announces Agenda for the 11th Session of Its Hearings On Competition and Consumer Protection in the 21st Century
Date
The Federal Trade Commission today announced the agenda for the 11th session of its Hearings Initiative, which will focus on the agency’s international work. The hearing, co-sponsored with the George...
1903004 Informal Interpretation
Date
Rule
801.1(a)(2)
Agree with your analysis.
File
Original Image
(100.63 KB)
James L. Dolan
James L. Dolan, Executive Chairman of Madison Square Garden Company, has agreed to pay $609,810 in civil penalties to resolve Federal Trade Commission allegations that he violated the Hart-Scott-Rodino Act by failing to report in a timely manner his acquisition of voting securities in Madison Square Garden Company.
Type of Action
Federal
Last Updated
FTC Matter/File Number
181 0077
FTC Announces Agenda for the 13th Session of its Hearings on Competition and Consumer Protection in the 21st Century
Date
The Federal Trade Commission today announced the agenda for the thirteenth session of its Hearings Initiative. The session, focused on the agency’s merger retrospective program, will take place on...
Apr12
FTC Hearing #13: Merger Retrospectives
-
The Federal Trade Commission held the thirteenth session of its Hearings Initiative, focused on the agency’s merger retrospective program, on April 12, 2019, at FTC Headquarters in Room 432. This...
FTC Publishes Inflation-Adjusted Civil Penalty Amounts
Date
The Federal Trade Commission has adjusted the maximum civil penalty dollar amounts for violations of 16 provisions of law the FTC enforces, as required by the Federal Civil Penalties Inflation...
FTC Issues Modified Final Order Imposing Conditions on Merger of International Industrial Gas Suppliers Praxair, Inc. and Linde AG
Date
Following a public comment period, the Federal Trade Commission has approved a modified final order requiring industrial gas suppliers Praxair, Inc. and Linde AG to sell assets in nine industrial...
Last Remaining Defendant Settles FTC Suit that Led to Landmark Supreme Court Ruling on Drug Company “Reverse Payments”
Date
The Federal Trade Commission has reached a settlement in FTC v. Actavis, the 2009 FTC case alleging that the brand-name drug company Solvay and three generic drug companies illegally agreed to...
Watson Pharmaceuticals, Inc., et al. (FTC v. Actavis)
On 2/2/2009, the Commission filed a complaint in federal district court challenging and agreement between Solvay Pharmaceuticals and two generic drug manufacturers in which Solvay paid for the delayed release of generic equivalents to its own testosterone-replacement drug, AndroGel, typically used in the treatment of men with low testosterone levels due to advanced age, certain cancers, and HIV/AIDS. According to the Commission’s complaint, in an effort to prevent Watson Pharmaceuticals and Par Pharmaceuticals from acquiring patents for their competing testosterone replacement drugs, Solvay paid the companies to delay entry for a nine year period, ending in 2015.
This case was transferred from the United States District Court for the Central District of California to the Northern District of Georgia. The district court dismissed the Commission's complaint, and the Eleventh Circuit affirmed, holding that anticompetitive effects within the scope of patent protection are per se legal under the antitrust laws.
On 10/4/2012, the FTC filed a writ of certiorari to the Supreme Court. On June 17, 2013, the Supreme Court reversed the 11th Circuit, rejecting the scope of the patent test and permitting antitrust review of reverse payment patent settlement agreements.
There are three related administrative proceedings:
Type of Action
Federal
Last Updated
FTC Matter/File Number
071 0060
Displaying 1641 - 1660 of 4985